Lisanti Capital Growth LLC Purchases Shares of 8,300 HealthEquity, Inc. (NASDAQ:HQY)

Lisanti Capital Growth LLC purchased a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 8,300 shares of the company's stock, valued at approximately $796,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Arcadia Investment Management Corp MI purchased a new position in HealthEquity during the 4th quarter valued at about $26,000. Smartleaf Asset Management LLC increased its holdings in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after buying an additional 98 shares during the period. Proficio Capital Partners LLC purchased a new position in shares of HealthEquity in the 4th quarter valued at $39,000. UMB Bank n.a. grew its stake in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after purchasing an additional 164 shares during the last quarter. Finally, Lindbrook Capital LLC raised its holdings in HealthEquity by 27.6% in the fourth quarter. Lindbrook Capital LLC now owns 750 shares of the company's stock worth $72,000 after purchasing an additional 162 shares in the last quarter. Institutional investors own 99.55% of the company's stock.

HealthEquity Price Performance

Shares of HQY traded up $1.26 during mid-day trading on Tuesday, hitting $95.74. 888,641 shares of the company were exchanged, compared to its average volume of 649,958. The stock has a market cap of $8.30 billion, a price-to-earnings ratio of 87.83, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The company has a 50 day moving average of $105.75 and a 200-day moving average of $94.80. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

Remove Ads

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the previous year, the company posted $0.40 earnings per share. Analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HQY. Bank of America lifted their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a research report on Wednesday, November 13th. BTIG Research increased their price objective on HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a report on Thursday, November 14th. JMP Securities raised their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research report on Tuesday, December 10th. Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. Finally, Mizuho started coverage on HealthEquity in a report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price target for the company. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $113.54.

Insiders Place Their Bets

In related news, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.